Savara Inc SEC filings SVRA
Savara Inc has 1,000 filings in SEC EDGAR's recent list, going back to Jul 22, 2009. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jun 8, 2026 (officer or director change, bylaw or fiscal year change, shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 11, 2026 | — |
| 424B5 | Prospectus supplement | Oct 30, 2025 | — |
| 424B5 | Prospectus supplement | Oct 29, 2025 | — |
| S-8 | Employee stock plan registration | Oct 1, 2024 | — |
| S-8 | Employee stock plan registration | Jul 26, 2024 | — |
| 424B5 | Prospectus supplement | Jun 28, 2024 | — |
| S-3 | Shelf registration | May 9, 2024 | — |
| S-8 | Employee stock plan registration | Mar 7, 2024 | — |
| 424B5 | Prospectus supplement | Jul 13, 2023 | — |
| S-8 | Employee stock plan registration | Jun 16, 2023 | — |
| S-8 | Employee stock plan registration | Mar 30, 2023 | — |
| S-8 | Employee stock plan registration | Jan 20, 2023 | — |
| S-8 | Employee stock plan registration | Nov 21, 2022 | — |
| S-8 | Employee stock plan registration | Mar 30, 2022 | — |
| S-8 | Employee stock plan registration | Jul 6, 2021 | — |
| S-3 | Shelf registration | Jul 6, 2021 | — |
| 424B5 | Prospectus supplement | Mar 12, 2021 | — |
| 424B5 | Prospectus supplement | Mar 10, 2021 | — |
| 424B3 | Prospectus | Apr 30, 2020 | — |
| S-8 | Employee stock plan registration | Apr 17, 2020 | — |
| S-3 | Shelf registration | Apr 17, 2020 | — |
| 424B5 | Prospectus supplement | Jul 26, 2018 | — |
| 424B5 | Prospectus supplement | Jul 25, 2018 | — |
| S-8 | Employee stock plan registration | Jun 29, 2018 | — |
| S-3 | Shelf registration | Jun 29, 2018 | — |
| 424B5 | Prospectus supplement | Oct 26, 2017 | — |
| 424B5 | Prospectus supplement | Oct 24, 2017 | — |
| 424B5 | Prospectus supplement | Jun 6, 2017 | — |
| 424B5 | Prospectus supplement | Jun 1, 2017 | — |
| S-8 | Employee stock plan registration | May 11, 2017 | — |
| 424B5 | Prospectus supplement | May 1, 2017 | — |
| 424B3 | Prospectus | Mar 15, 2017 | — |
| S-4/A | Filing | Mar 13, 2017 | — |
| S-4 | Registration for a merger or exchange | Feb 10, 2017 | — |
| 424B3 | Prospectus | May 16, 2016 | — |
| POS AM | Filing | May 13, 2016 | — |
| POS AM | Filing | May 6, 2016 | — |
| 424B5 | Prospectus supplement | Feb 11, 2016 | — |
| 424B5 | Prospectus supplement | Feb 9, 2016 | — |
| 424B5 | Prospectus supplement | Aug 21, 2015 | — |
| S-8 | Employee stock plan registration | Aug 12, 2015 | — |
| S-3/A | Filing | Aug 12, 2015 | — |
| S-3 | Shelf registration | Mar 24, 2015 | — |
| 424B5 | Prospectus supplement | Nov 7, 2014 | — |
| 424B5 | Prospectus supplement | Nov 5, 2014 | — |
| S-8 | Employee stock plan registration | Aug 11, 2014 | — |
| 424B5 | Prospectus supplement | May 14, 2014 | — |
| POS AM | Filing | May 5, 2014 | — |
| POS AM | Filing | Mar 26, 2014 | — |
| 424B3 | Prospectus | Feb 28, 2014 | — |
| 424B3 | Prospectus | Feb 10, 2014 | — |
| 424B5 | Prospectus supplement | Feb 10, 2014 | — |
| 424B3 | Prospectus | Jan 8, 2014 | — |
| 424B3 | Prospectus | Nov 4, 2013 | — |
| 424B3 | Prospectus | Oct 30, 2013 | — |
| 424B3 | Prospectus | Aug 9, 2013 | — |
| S-8 | Employee stock plan registration | Aug 5, 2013 | — |
| 424B3 | Prospectus | Aug 5, 2013 | — |
| 424B3 | Prospectus | Jun 26, 2013 | — |
| 424B4 | Prospectus | Jun 17, 2013 | — |
| FWP | Free writing prospectus | Jun 14, 2013 | — |
| S-1/A | Amended registration statement | Jun 14, 2013 | — |
| S-1/A | Amended registration statement | Jun 13, 2013 | — |
| FWP | Free writing prospectus | Jun 10, 2013 | — |
| S-1/A | Amended registration statement | Jun 5, 2013 | — |
| S-1 | Registration statement | May 28, 2013 | — |
| S-3 | Shelf registration | Mar 8, 2012 | — |
| 424B5 | Prospectus supplement | Nov 14, 2011 | — |
| 424B5 | Prospectus supplement | Nov 10, 2011 | — |
| 424B3 | Prospectus | Oct 13, 2011 | — |
| S-3/A | Amendment no. 1 to form s-3 | Oct 6, 2011 | — |
| S-8 | Employee stock plan registration | Jun 16, 2011 | — |
| S-3 | Shelf registration | May 13, 2011 | — |
| POS AM | Post-effective amendment no. 4 | May 10, 2011 | — |
| POS AM | Filing | Apr 28, 2011 | — |
| POS AM | Filing | Mar 10, 2011 | — |
| 424B5 | Prospectus supplement | Jan 7, 2011 | — |
| 424B5 | Prospectus supplement | Jan 7, 2011 | — |
| 424B3 | Prospectus | Nov 8, 2010 | — |
| 424B3 | Prospectus | Aug 10, 2010 | — |
| 424B3 | Prospectus | May 3, 2010 | — |
| 424B5 | Prospectus supplement | May 3, 2010 | — |
| 424B3 | Prospectus | Apr 27, 2010 | — |
| S-3 | Shelf registration | Mar 25, 2010 | — |
| POS AM | Post-effective amendment no. 1 | Mar 18, 2010 | — |
| 424B3 | Prospectus | Mar 1, 2010 | — |
| 424B3 | Prospectus | Feb 11, 2010 | — |
| 424B3 | Prospectus | Jan 4, 2010 | — |
| 424B5 | Prospectus supplement | Jan 4, 2010 | — |
| S-3MEF | Filing | Jan 4, 2010 | — |
| 424B3 | Prospectus | Jan 4, 2010 | — |
| 424B3 | Prospectus | Nov 10, 2009 | — |
| S-1MEF | Filing | Oct 6, 2009 | — |
| 424B4 | Prospectus | Oct 6, 2009 | — |
| FWP | Free writing prospectus | Oct 5, 2009 | — |
| S-1/A | Amended registration statement | Oct 5, 2009 | — |
| S-1/A | Amended registration statement | Sep 25, 2009 | — |
| S-1/A | Amended registration statement | Sep 3, 2009 | — |
| 424B5 | Prospectus supplement | Aug 5, 2009 | — |
| S-1 | Registration statement | Jul 24, 2009 | — |
Showing 100 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SVRA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Austin, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1160308
- Former names
- Mast Therapeutics, Inc. (until Apr 25, 2017); ADVENTRX PHARMACEUTICALS INC (until Mar 1, 2013); BIOKEYS PHARMACEUTICALS INC (until May 15, 2003)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.